Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Azzur Labs is a life sciences services company focused on analytical and microbiological laboratory testing, environmental monitoring, calibration, and related GxP compliance support for pharmaceutical, biotechnology, medical device, and healthcare customers. The business historically operated as part of Azzur Group and served clients across product development, manufacturing, and quality operations rather than developing proprietary therapeutics. Its offerings have included analytical testing, microbiological testing, visual and particulate testing, environmental monitoring, and scientific advisory services. In 2025, Azzur Labs and MML were combined and rebranded as Gillson Sciences, indicating that Azzur Labs continues operationally as part of an acquired platform rather than as a standalone independent brand. The company is therefore best characterized as a commercial laboratory services and compliance partner to regulated healthcare industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Azzur Labs.